VelazquezEJLeeKLDejaMA. Coronary-artery bypass surgery in patients with left ventricular dysfunction. N Engl J Med. 2011;364(17):1607–1616.
2.
ZhangDLyuSSongX. Coronary artery bypass grafting versus percutaneous coronary intervention in patients with left ventricular systolic dysfunction: a meta-analysis. Angiology. 2017;68(1):19–28.
3.
FarkouchMEDomanskiMSleeperLA. Strategies for multivessel revascularization in patients with diabetes. N Engl J Med. 2012;367(25):2375–2384.
4.
MontalescotGSechtemUAchenbachS. 2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J. 2013;34(38):2949–3003.
5.
RoffiMPatronoCColletJP. 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology. Eur Heart J. 2016;37(3):267–315.
6.
WindeckerSKohlPhAlfonsoS. 2014 ESC/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2014;35(37):2541–2619.
7.
MosesJWLeonMBPopmaJJ. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med. 2003;349(14):1315-1323.
8.
WallentinLBeckerRBudajA. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2009;361(11):1045–1057.
9.
WiviottSDBraunwaldEMcCabeCH. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2007;357(20):2001–2015.
10.
HannanELWuCWalfordG. Drug-eluting stents vs. coronary-artery bypass grafting in multivessel coronary disease. N Engl J Med. 2008;358(4):331–341.
11.
BonowROMaurerGLeeKL. Myocardial viability and survival in ischemic left ventricular dys- function. N Engl J Med. 2011;364(17):1617–1625.
12.
LingLFMarwickTHFloresDR. Identification of therapeutic benefit from revascularization in patients with left ventricular systolic dysfunction: inducible ischemia vs. hibernating myocardium. Circ Cardiovasc Imaging. 2013;6(3):363–372.
13.
PruczRBWeissESPatelNDNwakannaLUBaumgartnerWAConteJV. Coronary artery bypass grafting with or without surgical ventricular restoration: a comparison. Ann Thorac Surg. 2008;86(3):806–814.
14.
JonesRHVelazquezEJMichlerRE. Coronary bypass surgery with or without surgical ventricular reconstruction. N Engl J Med. 2009;360(17):1705–1717.
